February 11, 2022
1 min learn
The American Faculty of Rheumatology has up to date its suggestions relating to the COVID-19 vaccine for sufferers with rheumatic ailments.
The group now recommends a fourth mRNA COVID-19 vaccine dose for sufferers on immunosuppressants and immunomodulatory remedy. This replace in scientific steerage was the highest story in rheumatology final week.
One other prime story coated information revealed in The Journal of Rheumatology that exposed better COVID-19 vaccine uptake amongst sufferers with immune-mediated inflammatory illness in contrast with the overall inhabitants.
Learn these and extra prime tales in rheumatology beneath:
ACR recommends fourth dose of COVID-19 mRNA vaccine for sufferers on immunosuppressants
The American Faculty of Rheumatology has up to date its COVID-19 vaccine scientific steerage for sufferers with rheumatic ailments to suggest a fourth mRNA vaccine dose in sufferers receiving immunosuppressive or immunomodulatory remedy. Read more.
COVID-19 vaccine uptake increased amongst sufferers with IMIDs than common inhabitants
Roughly 83% to 88% of Canadian sufferers with immune-mediated inflammatory illness have obtained two doses of a COVID-19 vaccine, in contrast with 78% of the overall inhabitants, in response to information revealed in The Journal of Rheumatology. Read more.
‘No clinically related impact’: Duloxetine fails to impression persistent osteoarthritis ache
Including duloxetine to standard care fails to lead to any “clinically related impact” in sufferers with persistent hip or knee osteoarthritis ache, in contrast with standard care alone, in response to information revealed in Arthritis & Rheumatology. Read more.
Almost 1 in 6 sufferers with RA develop interstitial lung illness inside 20 years
Greater than 15% of sufferers with rheumatoid arthritis develop interstitial lung illness inside 20 years, with the latter situation related to shorter survival, in response to information revealed in Arthritis Care & Analysis. Read more.
Hooked on Rheum with Kenneth Saag, MD
As an undergrad, I studied bioengineering. Once I began finding out medication, I discovered that the musculoskeletal system had essentially the most in reference to my biomechanics pursuits. That’s what initially attracted me to contemplate rheumatology, orthopedics and bodily medication and rehabilitation. Read more.